Works matching IS 15674215 AND DT 2017 AND VI 19 AND IP 6


Results: 16
    1

    Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.

    Published in:
    European Journal of Heart Failure. Supplements, 2017, v. 19, n. 6, p. 800, doi. 10.1002/ejhf.830
    By:
    • Teerlink, John R.;
    • Voors, Adriaan A.;
    • Ponikowski, Piotr;
    • Pang, Peter S.;
    • Greenberg, Barry H.;
    • Filippatos, Gerasimos;
    • Felker, G. Michael;
    • Davison, Beth A.;
    • Cotter, Gad;
    • Gimpelewicz, Claudio;
    • Boer-Martins, Leandro;
    • Wernsing, Margaret;
    • Hua, Tsushung A.;
    • Severin, Thomas;
    • Metra, Marco
    Publication type:
    Article
    2
    3

    Impact of eplerenone on cardiovascular outcomes in heart failure patients with hypokalaemia.

    Published in:
    European Journal of Heart Failure. Supplements, 2017, v. 19, n. 6, p. 792, doi. 10.1002/ejhf.688
    By:
    • Rossignol, Patrick;
    • Girerd, Nicolas;
    • Bakris, George;
    • Vardeny, Orly;
    • Claggett, Brian;
    • McMurray, John J. V.;
    • Swedberg, Karl;
    • Krum, Henry;
    • van Veldhuisen, Dirk J.;
    • Shi, Harry;
    • Spanyers, Sean;
    • Vincent, John;
    • Fay, Renaud;
    • Lamiral, Zohra;
    • Solomon, Scott D.;
    • Zannad, Faiez;
    • Pitt, Bertram
    Publication type:
    Article
    4
    5
    7
    8
    9
    10
    11

    Circular RNAs in heart failure.

    Published in:
    European Journal of Heart Failure. Supplements, 2017, v. 19, n. 6, p. 701, doi. 10.1002/ejhf.801
    By:
    • Devaux, Yvan;
    • Creemers, Esther E.;
    • Boon, Reinier A.;
    • Werfel, Stanislas;
    • Thum, Thomas;
    • Engelhardt, Stefan;
    • Dimmeler, Stefanie;
    • Squire, Iain
    Publication type:
    Article
    12

    Plasma biomarkers to predict or rule out early post-discharge events after hospitalization for acute heart failure.

    Published in:
    European Journal of Heart Failure. Supplements, 2017, v. 19, n. 6, p. 728, doi. 10.1002/ejhf.766
    By:
    • Demissei, Biniyam G.;
    • Postmus, Douwe;
    • Cleland, John G.;
    • O'Connor, Christopher M.;
    • Metra, Marco;
    • Ponikowski, Piotr;
    • Teerlink, John R.;
    • Cotter, Gad;
    • Davison, Beth A.;
    • Givertz, Michael M.;
    • Bloomfield, Daniel M.;
    • van Veldhuisen, Dirk J.;
    • Dittrich, Howard C.;
    • Hillege, Hans L.;
    • Voors, Adriaan A.
    Publication type:
    Article
    13
    14

    New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment.

    Published in:
    European Journal of Heart Failure. Supplements, 2017, v. 19, n. 6, p. 718, doi. 10.1002/ejhf.809
    By:
    • Cowie, Martin R.;
    • Filippatos, Gerasimos S.;
    • de los Angeles Alonso Garcia, Maria;
    • Anker, Stefan D.;
    • Baczynska, Anna;
    • Bloomfield, Daniel M.;
    • Borentain, Maria;
    • Slot, Karsten Bruins;
    • Cronin, Maureen;
    • Doevendans, Pieter A.;
    • El-Gazayerly, Amany;
    • Gimpelewicz, Claudio;
    • Honarpour, Narimon;
    • Janmohamed, Salim;
    • Janssen, Heidi;
    • Kim, Albert M.;
    • Lautsch, Dominik;
    • Laws, Ian;
    • Lefkowitz, Martin;
    • Lopez-Sendon, Jose
    Publication type:
    Article
    15

    Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure--does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS)

    Published in:
    European Journal of Heart Failure. Supplements, 2017, v. 19, n. 6, p. 739, doi. 10.1002/ejhf.786
    By:
    • Cleland, John G. F.;
    • Teerlink, John R.;
    • Davison, Beth A.;
    • Shoaib, Ahmad;
    • Metra, Marco;
    • Senger, Stefanie;
    • Milo, Olga;
    • Cotter, Gad;
    • Bourge, Robert C.;
    • Parker, John D.;
    • Jondeau, Guillaume;
    • Krum, Henry;
    • O'Connor, Christopher M.;
    • Torre-Amione, Guillermo;
    • van Veldhuisen, Dirk J.;
    • McMurray, John J. V.
    Publication type:
    Article
    16